Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hantavirus Vaccines
Research from Karolinska Institute broadens understanding of hantavirus vaccines
April 23rd, 2008
Scientists discuss in 'Passive immunization protects cynomolgus macaques against Puumala hantavirus challenge' new findings in hantavirus. "Hantaviruses cause two severe and often fatal human diseases: haemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). Presently, there is no effective prevention available for HFRS or HPS," scientists writing in the journal Antiviral Therapy report. "Here, we studied the effect of passive immunization on the course of infection in cynomolgus macaques challenged with wild-type Puumala hantavirus (PUUV-wt). A pool of serum drawn from previously PUUV-wt-infected monkeys was used for immunization; a...
Source: Vaccine Weekly (2008-04-23)
|
